drugset / Trial / NCT00252369

Treatment of Perianal Crohn's Disease, Combining Medical and Surgical Treatment.

NCT00252369

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study is aimed to assess the hypothesis that instillation of fibrin glue with the induction of local conditions using Infliximab, may be useful in the treatment of perianal Crohn's disease.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Infliximab Monoclonal antibody